Literature DB >> 33443546

Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic.

James C Robinson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33443546     DOI: 10.1001/jama.2020.25384

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Sustainable development goals under threat? Multidimensional impact of COVID-19 on our planet and society outweigh short term global pollution reduction.

Authors:  Abdul Qadeer; M Anis; Zeeshan Ajmal; Kelly L Kirsten; Muhammad Usman; Rivoningo R Khosa; Mengyang Liu; Xia Jiang; Xingru Zhao
Journal:  Sustain Cities Soc       Date:  2022-05-22       Impact factor: 10.696

Review 2.  COVID-19: vaccination problems.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-05-14       Impact factor: 5.476

3.  [Risk of Publication Bias in Therapeutic Interventions for COVID-19Risco de viés de publicação em intervenções terapêuticas para a COVID-19].

Authors:  Santiago Hasdeu; Fernando Tortosa
Journal:  Rev Panam Salud Publica       Date:  2021-12-16

Review 4.  Patients Access to Medicines - A Critical Review of the Healthcare System in Kenya.

Authors:  Anthony Martin Toroitich; Louise Dunford; Rachel Armitage; Sangeeta Tanna
Journal:  Risk Manag Healthc Policy       Date:  2022-03-01

Review 5.  Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results.

Authors:  Stephanie Rennane; Lawrence Baker; Andrew Mulcahy
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

6.  Vaccination Rate and Incidence of COVID-19 and Case Fatality Rate (CFR): A Correlational Study Using Data From 2019 to 2021.

Authors:  Jayakumary Muttappallymyalil; Satish Chandrasekhar Nair; Ramadas Changerath; Anusha Sreejith; Sashank Manda; Jayadevan Sreedharan
Journal:  Cureus       Date:  2022-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.